{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T01:25:32Z","timestamp":1782523532721,"version":"3.54.5"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2011,4,13]],"date-time":"2011-04-13T00:00:00Z","timestamp":1302652800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1007\/s00415-011-6036-7","type":"journal-article","created":{"date-parts":[[2011,4,12]],"date-time":"2011-04-12T21:53:01Z","timestamp":1302645181000},"page":"1865-1870","source":"Crossref","is-referenced-by-count":36,"title":["Elevated serum level of interleukin-32\u03b1 in the patients with myasthenia gravis"],"prefix":"10.1007","volume":"258","author":[{"given":"Sang-Jun","family":"Na","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seon-Hwa","family":"So","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kee Ook","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-Chul","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,4,13]]},"reference":[{"key":"6036_CR1","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/79792","volume":"1","author":"FD Shi","year":"2000","unstructured":"Shi FD, Wang HB, Li H, Hong S, Taniguchi M, Link H, Van Kaer L, Ljunggren HG (2000) Natural killer cells determine the outcome of B cell-mediated autoimmunity. Nat Immunol 1:245\u2013251","journal-title":"Nat Immunol"},{"key":"6036_CR2","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1172\/JCI29894","volume":"116","author":"BM Conti-Fine","year":"2006","unstructured":"Conti-Fine BM, Milani M, Kaminski HJ (2006) Myasthenia gravis: past, present and future. J Clin Invest 116:2843\u20132854","journal-title":"J Clin Invest"},{"key":"6036_CR4","doi-asserted-by":"crossref","first-page":"597","DOI":"10.4049\/jimmunol.148.2.597","volume":"148","author":"CA Dahl","year":"1992","unstructured":"Dahl CA, Schall RP, He HL, Cairns JS (1992) Identification of a novel gene expressed inactivated natural killer cells and T cells. J Immunol 148:597\u2013603","journal-title":"J Immunol"},{"key":"6036_CR5","first-page":"131","volume":"22","author":"SH Kim","year":"2005","unstructured":"Kim SH, Han SY, Azam T, Yoon DY, Dinarello CA (2005) Interleukin-32: a cytokine and inducer of TNF alpha. Immunity 22:131\u2013142","journal-title":"Immunity"},{"issue":"Suppl 3","key":"6036_CR6","doi-asserted-by":"crossref","first-page":"iii61","DOI":"10.1136\/ard.2006.058511","volume":"65","author":"CA Dinarello","year":"2006","unstructured":"Dinarello CA, Kim SH (2006) IL-32, a novel cytokine with a possible role in disease. Ann Rheum Dis 65(Suppl 3):iii61\u2013iii64","journal-title":"Ann Rheum Dis"},{"key":"6036_CR7","doi-asserted-by":"crossref","first-page":"557","DOI":"10.4049\/jimmunol.181.1.557","volume":"181","author":"MF Nold","year":"2008","unstructured":"Nold MF, Nold-Petry CA, Pott GB, Zepp JA, Saavedra MT, Kim SH, Dinarello CA (2008) Endogenous IL-32 controls cytokine and HIV-1 production. J Immunol 181:557\u2013565","journal-title":"J Immunol"},{"key":"6036_CR8","doi-asserted-by":"crossref","first-page":"3298","DOI":"10.1073\/pnas.0511233103","volume":"103","author":"LA Joosten","year":"2006","unstructured":"Joosten LA, Netea MG, Kim SH, Yoon DY, Oppers-Walgreen B, Radstake TR, Barrera P, van de Loo FA, Dinarello CA, van den Berg WB (2006) IL-32, a proinflammatory cytokine in rheumatoid arthritis. Proc Natl Acad Sci USA 103:3298\u20133303","journal-title":"Proc Natl Acad Sci USA"},{"key":"6036_CR9","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/j.1365-2249.2007.03439.x","volume":"149","author":"M Shioya","year":"2007","unstructured":"Shioya M, Nishida A, Yagi Y, Ogawa A, Tsujikawa T, Kim-Mitsuyama S, Takayanagi A, Shimizu N, Fujiyama Y, Andoh A (2007) Epithelial overexpression of interleukin-32alpha in inflammatory bowel disease. Clin Exp Immunol 149:480\u2013486","journal-title":"Clin Exp Immunol"},{"key":"6036_CR10","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1212\/WNL.55.1.16","volume":"55","author":"A Jaretzki 3rd","year":"2000","unstructured":"Jaretzki A 3rd, Barohn RJ, Ernstoff RM, Kaminski HJ, Keesey JC, Penn AS, Sanders DB (2000) Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America. Neurology 55:16\u201323","journal-title":"Neurology"},{"key":"6036_CR11","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1056\/NEJM199406233302507","volume":"330","author":"DB Drachman","year":"1994","unstructured":"Drachman DB (1994) Myasthenia gravis. N Engl J Med 330:1797\u20131810","journal-title":"N Engl J Med"},{"key":"6036_CR12","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.autrev.2006.08.015","volume":"6","author":"P Conti","year":"2007","unstructured":"Conti P, Youinou P, Theoharides TC (2007) Modulation of autoimmunity by the latest interleukins (with special emphasis on IL-32). Autoimmun Rev 6:131\u2013137","journal-title":"Autoimmun Rev"},{"key":"6036_CR13","doi-asserted-by":"crossref","first-page":"16309","DOI":"10.1073\/pnas.0508237102","volume":"102","author":"MG Netea","year":"2005","unstructured":"Netea MG, Azam T, Ferwerda G, Girardin SE, Walsh M, Park JS, Abraham E, Kim JM, Yoon DY, Dinarello CA, Kim SH (2005) IL-32 synergizes with nucleotide oligomerization domain (NOD) 1 and NOD2 ligands for IL-1beta and IL-6 production through a caspase 1-dependent mechanism. Proc Natl Acad Sci USA 102:16309\u201316314","journal-title":"Proc Natl Acad Sci USA"},{"key":"6036_CR14","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1212\/WNL.59.2.287","volume":"59","author":"S Jander","year":"2002","unstructured":"Jander S, Stoll G (2002) Increased serum levels of the interferon-gamma-inducing cytokine interleukin-18 in myasthenia gravis. Neurology 59:287\u2013289","journal-title":"Neurology"},{"key":"6036_CR15","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.4049\/jimmunol.163.5.2403","volume":"163","author":"R Furlan","year":"1999","unstructured":"Furlan R, Martino G, Galbiati F, Poliani PL, Smiroldo S, Bergami A, Desina G, Comi G, Flavell R, Su MS, Adorini L (1999) Caspase-1 regulates the inflammatory process leading to autoimmune demyelination. J Immunol 163:2403\u20132409","journal-title":"J Immunol"},{"key":"6036_CR16","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/nature01661","volume":"423","author":"GS Firestein","year":"2003","unstructured":"Firestein GS (2003) Evolving concepts of rheumatoid arthritis. Nature 423:356\u2013361","journal-title":"Nature"},{"key":"6036_CR17","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0016-5085(95)90277-5","volume":"109","author":"HM Dullemen van","year":"1995","unstructured":"van Dullemen HM, van Deventer SJ, Hommes DW, Bijl HA, Jansen J, Tytgat GN, Woody J (1995) Treatment of Crohn\u2019s disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2). Gastroenterology 109:129\u2013135","journal-title":"Gastroenterology"},{"key":"6036_CR18","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1056\/NEJMoa030409","volume":"349","author":"CL Leonardi","year":"2003","unstructured":"Leonardi CL, Powers JL, Matheson RT, Goffe BS, Zitnik R, Wang A, Gottlieb AB, Etanercept Psoriasis Study Group (2003) Etanercept as monotherapy in patients with psoriasis. N Engl J Med 349:2014\u20132022","journal-title":"N Engl J Med"},{"key":"6036_CR19","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1006\/jaut.2002.0618","volume":"19","author":"RS Duan","year":"2002","unstructured":"Duan RS, Wang HB, Yang JS, Scallon B, Link H, Xiao BG (2002) Anti-TNF-alpha antibodies suppress the development of experimental autoimmune myasthenia gravis. J Autoimmun 19:169\u2013174","journal-title":"J Autoimmun"},{"key":"6036_CR20","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.4049\/jimmunol.169.2.1077","volume":"169","author":"C Deng","year":"2002","unstructured":"Deng C, Goluszko E, T\u00fcz\u00fcn E, Yang H, Christadoss P (2002) Resistance to experimental autoimmune myasthenia gravis in IL-6-deficient mice is associated with reduced germinal center formation and C3 production. J Immunol 169:1077\u20131083","journal-title":"J Immunol"},{"key":"6036_CR21","doi-asserted-by":"crossref","first-page":"2970","DOI":"10.4049\/jimmunol.139.9.2970","volume":"139","author":"DF Jelinek","year":"1987","unstructured":"Jelinek DF, Lipsky PE (1987) Enhancement of human B cell proliferation and differentiation by tumor necrosis factor-alpha and interleukin 1. J Immunol 139:2970\u20132976","journal-title":"J Immunol"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-011-6036-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-011-6036-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-011-6036-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T01:23:08Z","timestamp":1741137788000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-011-6036-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4,13]]},"references-count":20,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["6036"],"URL":"https:\/\/doi.org\/10.1007\/s00415-011-6036-7","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,4,13]]}}}